CooperSurgical Lawsuits Face Jurisdictional, Venue Challenges
"This (would not be a) ruling on the substance of plaintiffs' claims," Tiseme Zegeye of Lieff Cabraser Heimann & Bernstein, one of the attorneys for the plaintiffs, said. "This is determining where the lawsuits will play out. ... It's the first step in figuring out where these cases move forward and how they're going to play out."
Novo Nordisk Files Multiple Complaints Alleging Trademark Infringement, False Advertising Across U.S.
"We will continue to pursue legal action against those who provide potentially unsafe and ineffective compounded 'semaglutide' products and knowingly deceive patients who are seeking treatment, thereby eroding public trust in the safety of FDA-approved medicines," said Doug Langa, executive vice president, North America operations and president of Novo Nordisk.